Björn Löwenadler
Board Member
Neuroscience
alzinova
Sweden
Biography
Björn has extensive experience from preclinical, early clinical, and external partnering activities in different positions within Biotech and Large Pharma R&D. He is currently the Business Development Director of Toleranzia, Sweden, which he previously managed as CEO. Positions previously held by Björn include: Head of Molecular Biology at Pharmacia, Director of Discovery Sciences AstraZeneca R&D, Head of Discovery Research Biovitrum, CSO of Arexis AB, and Director of External Collaborations at AstraZeneca R&D.
Research Interest
Molecular Biology, Alzheimers and Neurosciences.
